Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
| The first 150 words of the full text of this article appear below. |
EDITOR
We appreciated Featherstone and Donovan's report about
patients' perspectives of participation in a randomised controlled trial.1 We recently investigated the ability of 40 middle
aged and elderly caregivers to understand and retain information about randomised controlled trials in patients with Alzheimer's disease.
Eighteen caregivers were men and 22 women, and their mean age was 64 (SD 6) (range 50-76). They had had a mean of 6 (3) years of schooling
(range 5-17), and their mean score in the minimental state examination
was 29 (1) (range 25-30). They were given information in a
semistructured manner, including information sheets. Twenty eight of
them could not explain why placebo, randomisation, and double blind
procedures were used. Furthermore, eight of them could not recall
anything other than a vague idea of participation in an
"experiment" and the possible use of a placebo for some unknown
reason. Using a four step scale to rate competency to participate in